Cardiovascular comorbidities in hospitalized psychiatric patients with diagnoses of schizophrenic and affective disorders

Katarina Djokic-Pjescic ,
Katarina Djokic-Pjescic
Jasmina Gutovic ,
Jasmina Gutovic
Jelica Tesic ,
Jelica Tesic
Slavica Djukic-Dejanovic ,
Slavica Djukic-Dejanovic
Igor Grbic ,
Igor Grbic
Jovana Cvetkovic
Jovana Cvetkovic

Published: 01.06.2016.

Volume 45, Issue 2 (2016)

pp. 83-88;

https://doi.org/10.5937/pramed1602083d

Abstract

A cardiovascular comorbidity (CVC) in psychiatric patients represents a simultaneous occurrence of a cardiovascular and a mental illness in the same patient regardless of the order of occurrence or of the cause and effect relationship that conjoins them. The objective was to determine the frequency and sort of the CVC in previously hospitalized patients with diagnoses of schizophrenic and affective disorders along with the differences in distribution of said disorders between the two groups of patients. Design-wise this is a retrospective study of intersections. It is based on the analytics of medical data (the history of disease along with the internal medicine consultant reviews) of the hospitalized patients in the Clinic for psychiatric disorders “Dr. Laza Lazarević” in Belgrade during the period between November 2014 and February 2015. Patients who were involved were older than 18 and they had diagnoses of schizophrenic disorders (F20-F29) and affective disorders (F30-F39), according to diagnostic criteria in the International classification of diseases 10 (ICD-10). CVC which were previously diagnosed or registered during the examination we separated into the following groups according to ICD-10: hypertension (HTA) I10, cardiac arrhythmia (CA) I47-I49, chronic cardiomyopathy (CMP) I42-I43 and ischemic heart disease (IHD) 120-125. The two groups of patients were analyzed according with socio-demographic characteristics (gender and age range) and CVC diagnosed according to MKB-10 classification. CVC were registered in 66% of the patients diagnosed with schizophrenia and 34% of the patients with affective disorders. Hypertension was most common in both groups of patients following with cardiac arrhythmia. Cardiac arrhythmias were statistically significantly more common in patients diagnosed with schizophrenic disorders (p<0.001) compared to patients with affective disorders. The frequency of hypertension, ischemic heart disease and chronic cardiomyopathy rises with age in both groups of patients. The results of this research confirm a high degree of CVC in hospitalized patients with diagnoses of schizophrenic and affective disorders (especially cardiac arrhythmia and hypertension). A multidisciplinary team is the key for diagnosing and monitoring patients with schizophrenic and affective diseases in both primary and secondary preventions.

Keywords

References

1.
Hert D, Correll M, Bobes H, Cetkovich-Bakmas J, Cohen M, Asai D, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011;52–77.
2.
Gardner-Sood P, Lally J, Smith S, Atakan Z, Ismail K, Greenwood K. Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial. Psychological Medicine. 2015;2619–29.
3.
2011;
4.
Ignaszewski M, Yip A, Fitzpatrick S. Schizophrenia and coronary artery disease. BCMJ. 2015;(4):154–7.
5.
Ringen PA, Engh JA, Birkenaes AB, Dieset I, Andreassen OA. Increased Mortality in Schizophrenia Due to Cardiovascular Disease – A Non-Systematic Review of Epidemiology, Possible Causes, and Interventions. Frontiers in Psychiatry. 2014;5.
6.
Musselman D, Evans D, Nemeroff C. The Relationship of Depression to Cardiovascular Disease. Epidemiology, Biology, and Treatment Arch Gen Psychiatry. 1998;580–92.
7.
Girardin F. Cardiac adverse reactions associated with psychotropic drugs. Dialogues Clin Neurosci. 2007;(1):92–5.
8.
Khasawneh FT, Shankar GS. Minimizing Cardiovascular Adverse Effects of Atypical Antipsychotic Drugs in Patients with Schizophrenia. Cardiology Research and Practice. 2014;2014:1–8.
9.
Hert D, Dekker M, Wood J, Kahl D, Holt K, Möller R, et al. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry. 2009;(6):412–24.
10.
Smith DJ, Martin D, McLean G, Langan J, Guthrie B, Mercer SW. Multimorbidity in bipolar disorder and undertreatment of cardiovascular disease: a cross sectional study. BMC Medicine. 2013;11(1).
11.
Beutel M, Schulz H. Comorbid psychological disorders in patients with chronic somatic diseases. Bundes Gesund Geseund. 2011;(1):15–21.
12.
Juckel G. Psychiatric disorders and their effects on mortality and morbidity. Versicherungsmedizin. 2014;(4):184–7.
13.
Friedrich F, Litvan Z, Freidl M. Comorbid somatic illness in psychiatric inpatiens-an analiysis of administrative data. Neuropsychiatr. 2015;(2):71–6.
14.
Holt R. The prevention of diabetes and cardiovascular disease in people with schizophrenia. Acta Psychiatr Scand. 2015;(2):86–96.
15.
Franco MC, P, Sanchez S, B, Criado R, N. Metabolic syndrome and cardiovascular risk in patients with schizophrenia, bipolar disorder and schizoafective disorder. Nutr hosp. 2015;(6):2715–7.
16.
Lambert T, Velakoulis D, Pantelis C. Medical comorbidity in schizophrenia. MJA. 2003;67–70.
17.
Pizzi C, Santarella L, Manfrini O, Chiavaroli M. Ischemic heart disease and depression: an underestimated clinical association.
18.
G Ital Cardiol (Romme). 2013;(7–8):526–37.
19.
Marić J. Klinička psihijatrija-XI prerađeno i dopunjeno izdanje. 2005;
20.
Bar K. Cardiac autonomic dysfunction in patients with schizophrenia and their healthy relatives-a small review. Front Neurol. 2015;139.
21.
Stahl S. 2009;
22.
Cardiac Adverse Effects of Psychotropic Medication in Schizophrenia. North Metropolitan Area Mental Health Service November. 2010;
23.
Đukić-Dejanović S, Psihijatrija U, Kragujevac. 2011;

Citation

Copyright

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by